ORCOSA Inc is founded in 2020, operates from its headquarter in 7 Graphics Dr Ewing, New Jersey 08628, US. The company operates in the Manufacturing, Pharmaceuticals sector.
ORCOSA Inc specializes in Therapeutic delivery systems, Drug absorption enhancement, Proprietary manufacturing processes, cGMP-compliant facility, Clinical trial support, and offers services including Rapid Infusion Technology (RITe™) Platform, ORAVEXX™, and Non-addictive cannabidiol composition.
Total Rounds
US$ 10.8M
Last Round
US$ 7.3M
Rounds
2